These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27085202)

  • 1. Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
    Lindblom RP; Aeinehband S; Ström M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
    Clin Immunol; 2016 May; 166-167():89-95. PubMed ID: 27085202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
    Aeinehband S; Lindblom RP; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
    PLoS One; 2015; 10(4):e0122048. PubMed ID: 25835709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis.
    Håkansson I; Ernerudh J; Vrethem M; Dahle C; Ekdahl KN
    J Neuroimmunol; 2020 Mar; 340():577147. PubMed ID: 31951875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2016 Dec; 22(6):823-830. PubMed ID: 27273074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
    Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
    Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG; Spruth M; Schoch J; Dierich MP; Prodinger WM
    J Immunol; 1997 Jun; 158(11):5455-63. PubMed ID: 9164968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in patients with neuromyelitis optica.
    Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M
    J Neuroimmunol; 2014 Sep; 274(1-2):185-91. PubMed ID: 25109258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in Lyme neuroborreliosis--increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS.
    Henningsson AJ; Ernerudh J; Sandholm K; Carlsson SA; Granlund H; Jansson C; Nyman D; Forsberg P; Nilsson Ekdahl K
    J Neuroimmunol; 2007 Feb; 183(1-2):200-7. PubMed ID: 17157926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3-dependent mechanism of microglial priming relevant to multiple sclerosis.
    Ramaglia V; Hughes TR; Donev RM; Ruseva MM; Wu X; Huitinga I; Baas F; Neal JW; Morgan BP
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):965-70. PubMed ID: 22219359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine).
    Bartosik-Psujek H; Stelmasiak Z; Mitosek-Szewczyk K; Belniak-Legieć E; Dobosz B
    Ann Univ Mariae Curie Sklodowska Med; 2000; 55():231-4. PubMed ID: 11482079
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Ramaglia V; Jackson SJ; Hughes TR; Neal JW; Baker D; Morgan BP
    Clin Exp Immunol; 2015 Jun; 180(3):432-41. PubMed ID: 25619542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome.
    Sladkova V; Mareš J; Lubenova B; Zapletalova J; Stejskal D; Hlustik P; Kanovsky P
    Neurol Res; 2011 May; 33(4):415-20. PubMed ID: 21535941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.